| 1 |
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study
Jean‐Michel Molina, Jaime Federico Andrade-Villanueva, Juan I. Echevarria et al. · The Lancet
|
Aug 2008 |
485 |
| 2 |
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
Kathryn Schnippel, Norbert O. Ndjeka, Gary Maartens et al. · The Lancet Respiratory Medicine
|
11 Jul 2018 |
264 |
| 3 |
Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1–Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study
Jean‐Michel Molina, Jaime Federico Andrade-Villanueva, Juan Echevarría et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
|
24 Feb 2010 |
256 |
| 4 |
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
Keertan Dheda et al. · The Lancet
|
May 2010 |
250 |
| 5 |
The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART
Frank van Leth, Shalini Andrews, Beatriz Gilda Jegerhorn Grinsztejn et al. · AIDS
|
11 Mar 2005 |
163 |
| 6 |
Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients
Daniel R Malan, Edrich Krantz, Neal David et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
|
Feb 2008 |
150 |
| 7 |
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen
Norbert O. Ndjeka, Kathryn Schnippel, Iqbal Master et al. · European Respiratory Journal
Open access |
25 Oct 2018 |
136 |
| 8 |
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study
Keertan Dheda et al. · The Lancet Respiratory Medicine
Open access |
19 Jan 2017 |
133 |
| 9 |
Hearing loss in patients on treatment for drug-resistant tuberculosis
James A. Seddon, Peter Godfrey‐Faussett, Kayleen Jacobs et al. · European Respiratory Journal
|
14 Jun 2012 |
128 |
| 10 |
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study
Nazir Ahmed Ismail et al. · The Lancet Infectious Diseases
|
12 Nov 2021 |
122 |
| 11 |
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
Brigitta Derendinger et al. · The Lancet Microbe
Open access |
3 Nov 2023 |
111 |
| 12 |
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)
Aliasgar Esmail et al. · American Journal of Respiratory and Critical Care Medicine
|
17 Feb 2022 |
99 |
| 13 |
Culture-Confirmed Multidrug-Resistant Tuberculosis in Children: Clinical Features, Treatment, and Outcome
James A. Seddon, Anneke Catharina Hesseling, M. Willemse et al. · Clinical Infectious Diseases
|
3 Nov 2011 |
99 |
| 14 |
Hearing loss in children treated for multidrug-resistant tuberculosis
James A. Seddon, Stephanie A. Thee, Kayleen Jacobs et al. · Journal of Infection
|
6 Sep 2012 |
85 |
| 15 |
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis
Grant Theron, Jason D. Limberis, Rouxjeane Venter et al. · Nature Medicine
Open access |
29 Jun 2020 |
77 |
| 16 |
Genetic Polymorphism inMycobacterium tuberculosisIsolates from Patients with Chronic Multidrug‐Resistant Tuberculosis
Frank A. Post, Paul A. Willcox, Barun Mathema et al. · The Journal of Infectious Diseases
|
11 Jun 2004 |
77 |
| 17 |
Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002.
Karen Shean, Paul A. Willcox, Sweetness Siwendu et al. · PubMed
|
Oct 2008 |
71 |
| 18 |
Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis
Marc Van Leuven, Mark de Groot, Karen Shean et al. · The Annals of Thoracic Surgery
|
May 1997 |
71 |
| 19 |
Drug–drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB
Mishal Pandie, Lubbe Wiesner, Helen McIlleron et al. · Journal of Antimicrobial Chemotherapy
|
7 Jan 2016 |
65 |
| 20 |
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
Richard Court, Chad M. Centner, Maxwell Chirehwa et al. · International Journal of Infectious Diseases
Open access |
7 Mar 2021 |
62 |
| 21 |
Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study
James C.M. Brust et al. · Clinical Infectious Diseases
Open access |
17 Apr 2021 |
49 |
| 22 |
Clinical Access Program for Bedaquiline for the treatment of drug-resistant tuberculosis
Francesca Conradie, Graeme Meintjes, Jennifer A. Hughes et al. · South African Medical Journal
Open access |
6 Feb 2014 |
45 |
| 23 |
Abnormal thyroid function tests in children on ethionamide treatment [Short communication]
Stephanie A. Thee, Ekkehard Werner Zöllner, Marianne Willemse et al. · The International Journal of Tuberculosis and Lung Disease
|
5 Aug 2011 |
39 |
| 24 |
LONG-TERM LINEZOLID TREATMENT IN A YOUNG CHILD WITH EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Hendrik Simon Schaaf, Marianne Willemse, Peter Roderick Donald · The Pediatric Infectious Disease Journal
|
Aug 2009 |
34 |
| 25 |
Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone
Maxwell Chirehwa, Richard Court, Mariana de Kock et al. · Antimicrobial Agents and Chemotherapy
Open access |
18 Aug 2020 |
31 |
| 26 |
Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis
Richard Court, Lubbe Wiesner, Annemie Stewart et al. · The International Journal of Tuberculosis and Lung Disease
Open access |
2018 |
28 |
| 27 |
Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?
Norbert O. Ndjeka, Jennifer A. Hughes, Anja Reuter et al. · The International Journal of Tuberculosis and Lung Disease
Open access |
Oct 2020 |
27 |
| 28 |
High Frequency of Resistance, Lack of Clinical Benefit, and Poor Outcomes in Capreomycin Treated South African Patients with Extensively Drug-Resistant Tuberculosis
Elize Pietersen, Jonny Peter, Elizabeth Maria Streicher et al. · PLoS ONE
Open access |
24 Apr 2015 |
23 |
| 29 |
Probable Levofloxacin-associated Secondary Intracranial Hypertension in a Child With Multidrug-resistant Tuberculosis
Louvina E. van der Laan, Hendrik Simon Schaaf, Regan Solomons et al. · The Pediatric Infectious Disease Journal
|
19 Mar 2016 |
21 |
| 30 |
96-Week Efficacy and Safety of Atazanavir, With and Without Ritonavir, in a HAART Regimen in Treatment-Naive Patients
Daniel R Malan, Edrich Krantz, Neal David et al. · Journal of the International Association of Physicians in AIDS Care
|
2010 |
20 |
| 31 |
Complications of Antiretroviral Therapy Initiation in Hospitalised Patients with HIV-Associated Tuberculosis
Helen van der Plas, Graeme Meintjes, Charlotte Schutz et al. · PLoS ONE
Open access |
8 Feb 2013 |
19 |
| 32 |
Delamanid, a new 6-nitro-2,3-dihydroimidazo[2,1-b]oxazole for the management of tuberculosis resistant to at least isoniazid and rifampicin
Andreas Henri Diacon, Florian von Groote-Bidlingmaier, Peter Roderick Donald · Expert Opinion on Orphan Drugs
|
25 Nov 2013 |
16 |
| 33 |
Lifestyle, attitudes and needs of uncured XDR ‐ TB patients living in the communities of South Africa: a qualitative study
Meera Senthilingam, Elize Pietersen, Ruth McNerney et al. · Tropical Medicine & International Health
|
5 May 2015 |
15 |
| 34 |
Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis
Richard Court, Maxwell Chirehwa, Lubbe Wiesner et al. · The International Journal of Tuberculosis and Lung Disease
Open access |
Oct 2019 |
14 |
| 35 |
Paediatric admissions to a TB hospital: reasons for admission, clinical profile and outcomes
H. K. Musonda, Penelope C. Rose, Juli Switala et al. · The International Journal of Tuberculosis and Lung Disease
|
24 Feb 2022 |
11 |
| 36 |
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis
Kamunkhwala Gausi, Maxwell Chirehwa, Elisa H. Ignatius et al. · Journal of Antimicrobial Chemotherapy
Open access |
9 Jun 2022 |
10 |
| 37 |
Acquired Drug Resistance During Inadequate Therapy in A Young Child with Tuberculosis
Anthony J. Garcia‐Prats, Marianne Willemse, H. I. Seifart et al. · The Pediatric Infectious Disease Journal
|
19 Mar 2014 |
10 |
| 38 |
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling
Maxwell Chirehwa, Juan Eduardo Reséndiz‐Galván, Richard Court et al. · Antimicrobial Agents and Chemotherapy
Open access |
6 Feb 2023 |
9 |
| 39 |
Successful Treatment of a Child With Extensively Drug-Resistant Tuberculous Meningitis: Figure 1.
Neele Alsleben, Anthony J. Garcia‐Prats, Anneke Catharina Hesseling et al. · Journal of the Pediatric Infectious Diseases Society
|
23 Dec 2014 |
9 |
| 40 |
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis
Huy Xuan Ngo et al. · Clinical Infectious Diseases
Open access |
11 Mar 2024 |
6 |
| 41 |
Effect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients
Maxwell Chirehwa, Richard Court, Mariana de Kock et al. · Antimicrobial Agents and Chemotherapy
Open access |
26 Jul 2021 |
6 |
| 42 |
Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
Norbert O. Ndjeka, Francesca Conradie, Graeme Meintjes et al. · European Respiratory Journal
Open access |
29 May 2020 |
5 |
| 43 |
Recruitment challenges for clinical trials with novel regimens for drug-resistant tuberculosis
Sweetness Siwendu, Melissa Gong Mitchell, Andreas Henri Diacon et al. · European Respiratory Journal
Open access |
2 Dec 2015 |
5 |
| 44 |
High frequency of bedaquiline resistance in programmatically treated drug-resistant TB patients with sustained culture-positivity in Cape Town, South Africa
Brigitta Derendinger et al. · medRxiv
PreprintOpen access |
14 Nov 2022 |
4 |
| 45 |
Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis
Richard Court, Lubbe Wiesner, Maxwell Chirehwa et al. · The International Journal of Tuberculosis and Lung Disease
Open access |
11 Jul 2018 |
4 |
| 46 |
Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household
Soyeon Kim et al. · PLoS ONE
Open access |
17 Mar 2023 |
3 |
| 47 |
Bartter-like syndrome caused by kanamycin during therapy for multidrug-resistant Mycobacterium tuberculosis
Mogamat‐Yazied Chothia, Jan H Esser, Nihal de Vries et al. · African Journal of Nephrology
Open access |
17 Mar 2018 |
3 |
| 48 |
HIV Infection and its Implications for Palliative Care in South Africa
Peter Alfred Kraus, Steve Andrews, Irene Tanchel · Progress in Palliative Care
|
2002 |
2 |
| 49 |
An All-Oral 6-Month Regimen for Multi-Drug Resistant/Rifampicin-Resistant Tuberculosis: A Multi-Centre, Phase 3, Open Label, Randomised Controlled Trial (NeXT Study)
Keertan Dheda et al. · SSRN Electronic Journal
PreprintOpen access |
2021 |
1 |
| 50 |
Linear diaphragmatic calcification in a two year-old child with tuberculosis
Irwan Taufiqur Rachman, Gerry R. Boss · South African Journal of Radiology
Open access |
31 May 1998 |
1 |